This post was originally published on this site
https://d1-invdn-com.investing.com/content/pic78ede0fa41fab6ae2874ab8bf5bb7e66.jpeg
Programmatic advertising platform Pubmatic (NASDAQ: NASDAQ:PUBM)
will be announcing earnings results tomorrow after the bell. Here’s what to look for.
Last quarter PubMatic reported revenues of $63.68 million, down 1.3% year on year, beating analyst revenue expectations by 7.1%. It was a very strong quarter for the company, with optimistic revenue guidance for the next quarter and a solid beat of analysts’ revenue estimates.
Is PubMatic buy or sell heading into the earnings? Find out by reading the original article on StockStory.
This quarter analysts are expecting PubMatic’s revenue to grow 5.2% year on year to $78.19 million, improving on the 1.7% year-over-year decline in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.30 per share.
Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company missed Wall St’s revenue estimates twice over the last two years.
Looking at PubMatic’s peers in the advertising software segment, some of them have already reported Q4 earnings results, giving us a hint of what we can expect. AppLovin (NASDAQ:APP) delivered top-line growth of 35.7% year on year, beating analyst estimates by 2.7% and LiveRamp reported revenues up 9.6% year on year, exceeding estimates by 1.2%. AppLovin traded up 13% on the results, and LiveRamp was down 2.3%.
Read the full analysis of AppLovin’s and LiveRamp’s results on StockStory.
Stocks have been under pressure as inflation (despite slowing) makes their long-dated profits less valuable, and while some of the advertising software stocks have fared somewhat better, they have not been spared, with share price declining 2.9% over the last month. PubMatic is up 2.7% during the same time, and is heading into the earnings with analyst price target of $17.9, compared to share price of $16.5.
